Letters to the Editor

Letters to the Editor

Advocating for a Return to Common Sense in Clinical Research

Mikkael Sekeres' reflections on Contract Research Agonizations inspired an impassioned response from our readers, with several writing in to express solidarity and share their own experiences...

Impatient Practicum

In his April 2017 Editor’s Corner, Editor-in-Chief Mikkael Sekeres issued his annual missive to the American Board of Internal Medicine (“Letter from a Cleveland...

Not-So-NICE One

In December 2016, we published an Online Exclusive item reporting on the United Kingdom’s National Institute for Health and Care Excellence’s (NICE) review of...

Another Clinical Research Secret

In the December 2016 Editor’s Corner (“So You Say You Want to Be a Clinical Researcher?”), Mikkael A. Sekeres, MD, MS, offered advice for...

The Family That Puzzles Together …

In December’s issue, Associate Editor David Steensma, MD, shared his lifelong love of word games, and how he went from fighting over the newspaper...

Marrow-Minded

In November’s Editor’s Corner, David Steensma, MD, recounted the “absurdly exotic experience” of eating bone marrow in a café in Milan after speaking about...

A Response on Email Etiquette

In October’s Editor’s Corner, Editor-in-Chief Mikkael A. Sekeres, MD, MS, and his colleague at Cleveland Clinic, Jennifer Lonzer, MA, provided “A Primer on Email...

More Reasons to Become a Hematologist…

In last month’s Editor’s Corner, Keith Stewart, MBChB, MBA, asked readers why they chose to join the ranks of the International Society of Bloody...

Don’t Fear the Filter

To the Editor: As an interventional radiologist who specializes in acute and chronic deep-vein thrombosis (DVT), superficial venous disease, and complex filter removal, I applaud...

Crippling Clinical Research?

I commend Dr. Sekeres for his excellent editorial (Take My Leftover Tissue, Please!), which appeared in the December 2015 issue of ASH Clinical News....
Advertisement

Current Issue

July 2017, Volume 3, Issue 8

This issue features an interview with the FDA's Richard Pazdur, highlights from the 2017 ASCO Annual Meeting, a debate about minimal residual disease in myeloma, and more.